History
  • No items yet
midpage
63 F. Supp. 3d 412
D.N.J.
2014
Read the full case

Background

  • Plaintiff purchased Excedrin Migraine in October 2013 in New Jersey to relieve migraines.
  • Plaintiff observed Excedrin Migraine and Excedrin Extra Strength appeared identical in ingredients and quantities, but paid more for Migraine believing it was more effective.
  • Plaintiff brings NJCFA and common law unjust enrichment claims on behalf of purchasers who paid higher prices for Excedrin Migraine since August 1, 2005.
  • Excedrin Migraine and Excedrin Extra Strength share the same formulation; Excedrin Migraine was FDA-approved in January 1998 with the same ingredients as Excedrin Extra Strength.
  • Defendant Briston-Myers Squibb sold both products at similar wholesale and suggested retail prices; current wholesale differentials exist by package size.
  • Court granted Defendant’s Rule 12(b)(6) dismissal without prejudice, with leave to amend).

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether pricing of identical products constitutes unconscionable practice under NJCFA Yingst argues pricing excess constitutes unconscionable practice Pricing differential is market-driven and not unconscionable Not a plausible NJCFA violation
Whether unjust enrichment claim states a cognizable quasi-contract theory Plaintiff paid for higher-priced Migraine product and may seek unjust enrichment Plaintiff received what she paid for; no unjust enrichment Dismissed unjust enrichment claim

Key Cases Cited

  • Bosland v. Warnock Dodge, Inc., 197 N.J. 543 (N.J. 2009) (NJCFA interpreted liberally; strong consumer protection policy)
  • Lee v. Carter-Reed Co., 203 N.J. 496 (N.J. 2010) (NJCFA framework and remedies including treble damages)
  • Furst v. Einstein Moomjy, Inc., 182 N.J. 1 (N.J. 2004) (NJCFA misrepresentation and unconscionable practices)
  • Sickles v. Cabot Corp., 379 N.J.Super. 100 (N.J. Super. Ct. App. Div. 2005) (historical context of NJCFA and unconscionable practices)
  • Turf Lawnmower Repair, Inc. v. Bergen Record Corp., 139 N.J. 392 (N.J. 1995) (definition of unconscionable commercial practice; liberal interpretation)
  • Cox v. Sears Roebuck & Co., 138 N.J. 2 (N.J. 1994) (good-faith and fair dealing standard in unconscionability prong)
  • Real v. Radir Wheels, Inc., 198 N.J. 511 (N.J. 2009) (unconscionable practices in advertising/sale)
  • Adamson v. Ortho-McNeil Pharm., Inc., 463 F.Supp.2d 496 (D.N.J. 2006) (unjust enrichment requires a benefit and unjust retention)
  • K-Dur Antitrust Litig., 338 F.Supp.2d 517 (D.N.J. 2004) (unjust enrichment analysis in pharmaceutical context)
  • Travelodge Hotels, Inc. v. Honeysuckle Enterprises, Inc., 357 F.Supp.2d 788 (D.N.J. 2005) (unconscionability standard similar to contract context)
Read the full case

Case Details

Case Name: Yingst v. Novartis AG
Court Name: District Court, D. New Jersey
Date Published: Nov 24, 2014
Citations: 63 F. Supp. 3d 412; 2014 WL 6791423; 2014 U.S. Dist. LEXIS 164749; Civil Action No. 13-7919
Docket Number: Civil Action No. 13-7919
Court Abbreviation: D.N.J.
Log In
    Yingst v. Novartis AG, 63 F. Supp. 3d 412